BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF

Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are disclosed.

Saved in:
Bibliographic Details
Main Authors ZHAO ZHENMING, BUSHNELL STEVEN, STEBBINS CHRISTOPHER, BUKO ALEXANDER MICHAEL, CADAVID DIEGO, WHALLEY ERIC TAYLOR
Format Patent
LanguageEnglish
Published 27.12.2012
Subjects
CHEMISTRY
COMBINATORIAL CHEMISTRY
HUMAN NECESSITIES
HYGIENE
LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES
MEDICAL OR VETERINARY SCIENCE
METALLURGY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are disclosed.
Bibliography:Application Number: US201213441745